Related Experiment Video
Updated: Jul 16, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Data saves lives: optimising routinely collected clinical data for rare disease research
Ameenat Lola Solebo1,2,3, Pirro Hysi4,5,6, Lisanne Andra Horvat-Gitsels4,7
1Population, Policy and Practice Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, 30 Guilford Street, London, WC1N 1EH, UK. a.solebo@ucl.ac.uk.
Healthcare providers are using innovations to manage health data post-pandemic. Engaging with health data informatics is crucial for rare disease research to avoid being left behind.
Area of Science:
- Health Informatics
- Data Science in Healthcare
- Clinical Data Management
Background:
- Post-pandemic organizational changes necessitate innovations in health data management.
- Real-world datasets of routinely collected clinical information are increasingly used for data-driven healthcare delivery.
Discussion:
- Rare diseases risk being overlooked without engagement in health data informatics.
- Challenges exist in the meaningful use and reuse of rare disease data.
- Addressing these challenges requires a concerted effort from clinical and research communities.
Key Insights:
- Recommendations include workforce education in health data informatics.
- Harmonization of taxonomy is essential for consistent data interpretation.
- Ensuring an inclusive health data environment is critical for all patient groups.
Outlook:
- Proactive engagement with health data informatics is vital for the rare disease community.
- Implementing proposed recommendations can facilitate better data utilization.
- This approach supports equitable advancement in rare disease research and care.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Statistical Software for Data Analysis and Clinical Trials
Analysis of Population Pharmacokinetic Data
Case Studies

